Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Narcolepsy Therapeutics Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Central nervous system stimulants
1.2.3 Sodium Oxybate
1.2.4 Selective Serotonin Reuptake Inhibitor (SSRI)
1.2.5 Tricyclic Antidepressants
1.2.6 Others
1.3 Market by Application
1.3.1 Global Narcolepsy Therapeutics Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Narcolepsy With Cataplexy
1.3.3 Narcolepsy Without Cataplexy
1.3.4 Secondary Narcolepsy
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Narcolepsy Therapeutics Market Perspective (2018-2033)
2.2 Narcolepsy Therapeutics Growth Trends by Region
2.2.1 Global Narcolepsy Therapeutics Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Narcolepsy Therapeutics Historic Market Size by Region (2018-2023)
2.2.3 Narcolepsy Therapeutics Forecasted Market Size by Region (2024-2033)
2.3 Narcolepsy Therapeutics Market Dynamics
2.3.1 Narcolepsy Therapeutics Industry Trends
2.3.2 Narcolepsy Therapeutics Market Drivers
2.3.3 Narcolepsy Therapeutics Market Challenges
2.3.4 Narcolepsy Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Narcolepsy Therapeutics Players by Revenue
3.1.1 Global Top Narcolepsy Therapeutics Players by Revenue (2018-2023)
3.1.2 Global Narcolepsy Therapeutics Revenue Market Share by Players (2018-2023)
3.2 Global Narcolepsy Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Narcolepsy Therapeutics Revenue
3.4 Global Narcolepsy Therapeutics Market Concentration Ratio
3.4.1 Global Narcolepsy Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Narcolepsy Therapeutics Revenue in 2022
3.5 Narcolepsy Therapeutics Key Players Head office and Area Served
3.6 Key Players Narcolepsy Therapeutics Product Solution and Service
3.7 Date of Enter into Narcolepsy Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Narcolepsy Therapeutics Breakdown Data by Type
4.1 Global Narcolepsy Therapeutics Historic Market Size by Type (2018-2023)
4.2 Global Narcolepsy Therapeutics Forecasted Market Size by Type (2024-2033)
5 Narcolepsy Therapeutics Breakdown Data by Application
5.1 Global Narcolepsy Therapeutics Historic Market Size by Application (2018-2023)
5.2 Global Narcolepsy Therapeutics Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Narcolepsy Therapeutics Market Size (2018-2033)
6.2 North America Narcolepsy Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Narcolepsy Therapeutics Market Size by Country (2018-2023)
6.4 North America Narcolepsy Therapeutics Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Narcolepsy Therapeutics Market Size (2018-2033)
7.2 Europe Narcolepsy Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Narcolepsy Therapeutics Market Size by Country (2018-2023)
7.4 Europe Narcolepsy Therapeutics Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Narcolepsy Therapeutics Market Size (2018-2033)
8.2 Asia-Pacific Narcolepsy Therapeutics Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Narcolepsy Therapeutics Market Size by Region (2018-2023)
8.4 Asia-Pacific Narcolepsy Therapeutics Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Narcolepsy Therapeutics Market Size (2018-2033)
9.2 Latin America Narcolepsy Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Narcolepsy Therapeutics Market Size by Country (2018-2023)
9.4 Latin America Narcolepsy Therapeutics Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Narcolepsy Therapeutics Market Size (2018-2033)
10.2 Middle East & Africa Narcolepsy Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Narcolepsy Therapeutics Market Size by Country (2018-2023)
10.4 Middle East & Africa Narcolepsy Therapeutics Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Addrenex Pharmaceuticals, Inc.
11.1.1 Addrenex Pharmaceuticals, Inc. Company Detail
11.1.2 Addrenex Pharmaceuticals, Inc. Business Overview
11.1.3 Addrenex Pharmaceuticals, Inc. Narcolepsy Therapeutics Introduction
11.1.4 Addrenex Pharmaceuticals, Inc. Revenue in Narcolepsy Therapeutics Business (2018-2023)
11.1.5 Addrenex Pharmaceuticals, Inc. Recent Development
11.2 Teva Pharmaceutical Industries Ltd.
11.2.1 Teva Pharmaceutical Industries Ltd. Company Detail
11.2.2 Teva Pharmaceutical Industries Ltd. Business Overview
11.2.3 Teva Pharmaceutical Industries Ltd. Narcolepsy Therapeutics Introduction
11.2.4 Teva Pharmaceutical Industries Ltd. Revenue in Narcolepsy Therapeutics Business (2018-2023)
11.2.5 Teva Pharmaceutical Industries Ltd. Recent Development
11.3 Jazz Pharmaceuticals PLC
11.3.1 Jazz Pharmaceuticals PLC Company Detail
11.3.2 Jazz Pharmaceuticals PLC Business Overview
11.3.3 Jazz Pharmaceuticals PLC Narcolepsy Therapeutics Introduction
11.3.4 Jazz Pharmaceuticals PLC Revenue in Narcolepsy Therapeutics Business (2018-2023)
11.3.5 Jazz Pharmaceuticals PLC Recent Development
11.4 Graymark Healthcare, Inc.
11.4.1 Graymark Healthcare, Inc. Company Detail
11.4.2 Graymark Healthcare, Inc. Business Overview
11.4.3 Graymark Healthcare, Inc. Narcolepsy Therapeutics Introduction
11.4.4 Graymark Healthcare, Inc. Revenue in Narcolepsy Therapeutics Business (2018-2023)
11.4.5 Graymark Healthcare, Inc. Recent Development
11.5 Arena Pharmaceuticals, Inc.
11.5.1 Arena Pharmaceuticals, Inc. Company Detail
11.5.2 Arena Pharmaceuticals, Inc. Business Overview
11.5.3 Arena Pharmaceuticals, Inc. Narcolepsy Therapeutics Introduction
11.5.4 Arena Pharmaceuticals, Inc. Revenue in Narcolepsy Therapeutics Business (2018-2023)
11.5.5 Arena Pharmaceuticals, Inc. Recent Development
11.6 BIOPROJET
11.6.1 BIOPROJET Company Detail
11.6.2 BIOPROJET Business Overview
11.6.3 BIOPROJET Narcolepsy Therapeutics Introduction
11.6.4 BIOPROJET Revenue in Narcolepsy Therapeutics Business (2018-2023)
11.6.5 BIOPROJET Recent Development
11.7 Takeda
11.7.1 Takeda Company Detail
11.7.2 Takeda Business Overview
11.7.3 Takeda Narcolepsy Therapeutics Introduction
11.7.4 Takeda Revenue in Narcolepsy Therapeutics Business (2018-2023)
11.7.5 Takeda Recent Development
11.8 Ligand Pharmaceuticals, Inc.
11.8.1 Ligand Pharmaceuticals, Inc. Company Detail
11.8.2 Ligand Pharmaceuticals, Inc. Business Overview
11.8.3 Ligand Pharmaceuticals, Inc. Narcolepsy Therapeutics Introduction
11.8.4 Ligand Pharmaceuticals, Inc. Revenue in Narcolepsy Therapeutics Business (2018-2023)
11.8.5 Ligand Pharmaceuticals, Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Narcolepsy Therapeutics Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Central nervous system stimulants
Table 3. Key Players of Sodium Oxybate
Table 4. Key Players of Selective Serotonin Reuptake Inhibitor (SSRI)
Table 5. Key Players of Tricyclic Antidepressants
Table 6. Key Players of Others
Table 7. Global Narcolepsy Therapeutics Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 8. Global Narcolepsy Therapeutics Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 9. Global Narcolepsy Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global Narcolepsy Therapeutics Market Share by Region (2018-2023)
Table 11. Global Narcolepsy Therapeutics Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 12. Global Narcolepsy Therapeutics Market Share by Region (2024-2033)
Table 13. Narcolepsy Therapeutics Market Trends
Table 14. Narcolepsy Therapeutics Market Drivers
Table 15. Narcolepsy Therapeutics Market Challenges
Table 16. Narcolepsy Therapeutics Market Restraints
Table 17. Global Narcolepsy Therapeutics Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global Narcolepsy Therapeutics Market Share by Players (2018-2023)
Table 19. Global Top Narcolepsy Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Narcolepsy Therapeutics as of 2022)
Table 20. Ranking of Global Top Narcolepsy Therapeutics Companies by Revenue (US$ Million) in 2022
Table 21. Global 5 Largest Players Market Share by Narcolepsy Therapeutics Revenue (CR5 and HHI) & (2018-2023)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Narcolepsy Therapeutics Product Solution and Service
Table 24. Date of Enter into Narcolepsy Therapeutics Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Narcolepsy Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global Narcolepsy Therapeutics Revenue Market Share by Type (2018-2023)
Table 28. Global Narcolepsy Therapeutics Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 29. Global Narcolepsy Therapeutics Revenue Market Share by Type (2024-2033)
Table 30. Global Narcolepsy Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 31. Global Narcolepsy Therapeutics Revenue Market Share by Application (2018-2023)
Table 32. Global Narcolepsy Therapeutics Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 33. Global Narcolepsy Therapeutics Revenue Market Share by Application (2024-2033)
Table 34. North America Narcolepsy Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. North America Narcolepsy Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 36. North America Narcolepsy Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 37. Europe Narcolepsy Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 38. Europe Narcolepsy Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 39. Europe Narcolepsy Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 40. Asia-Pacific Narcolepsy Therapeutics Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 41. Asia-Pacific Narcolepsy Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 42. Asia-Pacific Narcolepsy Therapeutics Market Size by Region (2024-2033) & (US$ Million)
Table 43. Latin America Narcolepsy Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Latin America Narcolepsy Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 45. Latin America Narcolepsy Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 46. Middle East & Africa Narcolepsy Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 47. Middle East & Africa Narcolepsy Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 48. Middle East & Africa Narcolepsy Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 49. Addrenex Pharmaceuticals, Inc. Company Detail
Table 50. Addrenex Pharmaceuticals, Inc. Business Overview
Table 51. Addrenex Pharmaceuticals, Inc. Narcolepsy Therapeutics Product
Table 52. Addrenex Pharmaceuticals, Inc. Revenue in Narcolepsy Therapeutics Business (2018-2023) & (US$ Million)
Table 53. Addrenex Pharmaceuticals, Inc. Recent Development
Table 54. Teva Pharmaceutical Industries Ltd. Company Detail
Table 55. Teva Pharmaceutical Industries Ltd. Business Overview
Table 56. Teva Pharmaceutical Industries Ltd. Narcolepsy Therapeutics Product
Table 57. Teva Pharmaceutical Industries Ltd. Revenue in Narcolepsy Therapeutics Business (2018-2023) & (US$ Million)
Table 58. Teva Pharmaceutical Industries Ltd. Recent Development
Table 59. Jazz Pharmaceuticals PLC Company Detail
Table 60. Jazz Pharmaceuticals PLC Business Overview
Table 61. Jazz Pharmaceuticals PLC Narcolepsy Therapeutics Product
Table 62. Jazz Pharmaceuticals PLC Revenue in Narcolepsy Therapeutics Business (2018-2023) & (US$ Million)
Table 63. Jazz Pharmaceuticals PLC Recent Development
Table 64. Graymark Healthcare, Inc. Company Detail
Table 65. Graymark Healthcare, Inc. Business Overview
Table 66. Graymark Healthcare, Inc. Narcolepsy Therapeutics Product
Table 67. Graymark Healthcare, Inc. Revenue in Narcolepsy Therapeutics Business (2018-2023) & (US$ Million)
Table 68. Graymark Healthcare, Inc. Recent Development
Table 69. Arena Pharmaceuticals, Inc. Company Detail
Table 70. Arena Pharmaceuticals, Inc. Business Overview
Table 71. Arena Pharmaceuticals, Inc. Narcolepsy Therapeutics Product
Table 72. Arena Pharmaceuticals, Inc. Revenue in Narcolepsy Therapeutics Business (2018-2023) & (US$ Million)
Table 73. Arena Pharmaceuticals, Inc. Recent Development
Table 74. BIOPROJET Company Detail
Table 75. BIOPROJET Business Overview
Table 76. BIOPROJET Narcolepsy Therapeutics Product
Table 77. BIOPROJET Revenue in Narcolepsy Therapeutics Business (2018-2023) & (US$ Million)
Table 78. BIOPROJET Recent Development
Table 79. Takeda Company Detail
Table 80. Takeda Business Overview
Table 81. Takeda Narcolepsy Therapeutics Product
Table 82. Takeda Revenue in Narcolepsy Therapeutics Business (2018-2023) & (US$ Million)
Table 83. Takeda Recent Development
Table 84. Ligand Pharmaceuticals, Inc. Company Detail
Table 85. Ligand Pharmaceuticals, Inc. Business Overview
Table 86. Ligand Pharmaceuticals, Inc. Narcolepsy Therapeutics Product
Table 87. Ligand Pharmaceuticals, Inc. Revenue in Narcolepsy Therapeutics Business (2018-2023) & (US$ Million)
Table 88. Ligand Pharmaceuticals, Inc. Recent Development
Table 89. Research Programs/Design for This Report
Table 90. Key Data Information from Secondary Sources
Table 91. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Narcolepsy Therapeutics Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Narcolepsy Therapeutics Market Share by Type: 2022 VS 2033
Figure 3. Central nervous system stimulants Features
Figure 4. Sodium Oxybate Features
Figure 5. Selective Serotonin Reuptake Inhibitor (SSRI) Features
Figure 6. Tricyclic Antidepressants Features
Figure 7. Others Features
Figure 8. Global Narcolepsy Therapeutics Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 9. Global Narcolepsy Therapeutics Market Share by Application: 2022 VS 2033
Figure 10. Narcolepsy With Cataplexy Case Studies
Figure 11. Narcolepsy Without Cataplexy Case Studies
Figure 12. Secondary Narcolepsy Case Studies
Figure 13. Narcolepsy Therapeutics Report Years Considered
Figure 14. Global Narcolepsy Therapeutics Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 15. Global Narcolepsy Therapeutics Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 16. Global Narcolepsy Therapeutics Market Share by Region: 2022 VS 2033
Figure 17. Global Narcolepsy Therapeutics Market Share by Players in 2022
Figure 18. Global Top Narcolepsy Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Narcolepsy Therapeutics as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by Narcolepsy Therapeutics Revenue in 2022
Figure 20. North America Narcolepsy Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. North America Narcolepsy Therapeutics Market Share by Country (2018-2033)
Figure 22. United States Narcolepsy Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Canada Narcolepsy Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe Narcolepsy Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Europe Narcolepsy Therapeutics Market Share by Country (2018-2033)
Figure 26. Germany Narcolepsy Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. France Narcolepsy Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. U.K. Narcolepsy Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Italy Narcolepsy Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Russia Narcolepsy Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Nordic Countries Narcolepsy Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Asia-Pacific Narcolepsy Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Asia-Pacific Narcolepsy Therapeutics Market Share by Region (2018-2033)
Figure 34. China Narcolepsy Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Japan Narcolepsy Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. South Korea Narcolepsy Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Southeast Asia Narcolepsy Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. India Narcolepsy Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Australia Narcolepsy Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Latin America Narcolepsy Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Latin America Narcolepsy Therapeutics Market Share by Country (2018-2033)
Figure 42. Mexico Narcolepsy Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Brazil Narcolepsy Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Middle East & Africa Narcolepsy Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Middle East & Africa Narcolepsy Therapeutics Market Share by Country (2018-2033)
Figure 46. Turkey Narcolepsy Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Saudi Arabia Narcolepsy Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Addrenex Pharmaceuticals, Inc. Revenue Growth Rate in Narcolepsy Therapeutics Business (2018-2023)
Figure 49. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Narcolepsy Therapeutics Business (2018-2023)
Figure 50. Jazz Pharmaceuticals PLC Revenue Growth Rate in Narcolepsy Therapeutics Business (2018-2023)
Figure 51. Graymark Healthcare, Inc. Revenue Growth Rate in Narcolepsy Therapeutics Business (2018-2023)
Figure 52. Arena Pharmaceuticals, Inc. Revenue Growth Rate in Narcolepsy Therapeutics Business (2018-2023)
Figure 53. BIOPROJET Revenue Growth Rate in Narcolepsy Therapeutics Business (2018-2023)
Figure 54. Takeda Revenue Growth Rate in Narcolepsy Therapeutics Business (2018-2023)
Figure 55. Ligand Pharmaceuticals, Inc. Revenue Growth Rate in Narcolepsy Therapeutics Business (2018-2023)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed